Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.32M Buy
9,182
+348
+4% +$119K 2.97% 9
2026
Q1
$3.11M Sell
8,834
-161
-2% -$57.4K 3.01% 10
2025
Q4
$2.94M Buy
8,995
+86
+1% +$27.3K 3.02% 10
2025
Q3
$2.51M Sell
8,909
-42
-0.5% -$12.2K 2.64% 12
2025
Q2
$2.5M Sell
8,951
-538
-6% -$152K 2.8% 12
2025
Q1
$2.96M Buy
9,489
+180
+2% +$53.2K 3.03% 11
2024
Q4
$2.43M Buy
9,309
+438
+5% +$130K 2.49% 13
2024
Q3
$2.86M Sell
8,871
-83
-0.9% -$27.1K 2.72% 12
2024
Q2
$2.8M Sell
8,954
-364
-4% -$107K 2.68% 12
2024
Q1
$2.65M Buy
9,318
+121
+1% +$35.4K 2.41% 15
2023
Q4
$2.65M Sell
9,197
-254
-3% -$69.2K 2.64% 14
2023
Q3
$2.54M Buy
9,451
+187
+2% +$46.7K 2.69% 15
2023
Q2
$2.06M Buy
9,264
+242
+3% +$56.2K 1.95% 17
2023
Q1
$2.18M Buy
9,022
+282
+3% +$69.2K 2.12% 16
2022
Q4
$2.3M Buy
+8,740
New +$2.34M 2.46% 15

Other funds holding AMGN

Crescent Sterling's AMGN Position: Q2 2026 in Review

Crescent Sterling increased its Amgen (AMGN) stake by 3.9% in Q2 2026, buying an estimated $119K and bringing the position to 9,182 shares worth $3.32M. The position accounts for 2.97% of the portfolio, ranked #9.

Crescent Sterling first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 1,353 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Crescent Sterling held 9,182 shares of Amgen worth $3.32M as of Q2 2026.
  • Crescent Sterling bought 348 Amgen shares in Q2 2026, an estimated $119K.
  • Amgen made up 2.97% of Crescent Sterling's portfolio in Q2 2026, its #9 holding.
  • Crescent Sterling first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 1,353 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Crescent Sterling's 13F filing for Q2 2026, filed 7 Jul 2026.